In HF with preserved ejection fraction (HFpEF), GLP-1 RAs may not reduce HF hospitalization but might lower atherosclerotic event risks [66, 67]
pneumoniae for the prediction of capsular type and the detection of virulence loci, including hypermucoidy genes rmpADC , rmpA2 , and siderophore systems, such as yersiniabactin ( ybt ), colibactin ( clb ), aerobactin ( iuc ), salmochelin ( iro ), as well as their associated mobile elements ( ICEKp )
Notably, the benefits appear to be more pronounced in patients with established ASCVD, reinforcing the importance of GLP-1 RAs as a cardioprotective intervention
When you swallow a traditional capsule, the harsh acids in your stomach often break down the glutathione molecule into its individual amino acids before it ever reaches your bloodstream
[3] Walker, R